Seguir
Frédéric Bost
Frédéric Bost
INSERM U1065, Université Côte d'Azur
E-mail confirmado em unice.fr
Título
Citado por
Citado por
Ano
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13489*2021
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
IB Sahra, K Laurent, A Loubat, S Giorgetti-Peraldi, P Colosetti, P Auberger, ...
Oncogene 27 (25), 3576-3586, 2008
10872008
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
I Ben Sahra, C Regazzetti, G Robert, K Laurent, Y Le Marchand-Brustel, ...
Cancer research 71 (13), 4366-4372, 2011
7072011
The role of MAPKs in adipocyte differentiation and obesity
F Bost, M Aouadi, L Caron, B Binétruy
Biochimie 87 (1), 51-56, 2005
6332005
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells
I Ben Sahra, K Laurent, S Giuliano, F Larbret, G Ponzio, P Gounon, ...
Cancer research 70 (6), 2465-2475, 2010
6212010
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
I Ben Sahra, Y Le Marchand-Brustel, JF Tanti, F Bost
Molecular cancer therapeutics 9 (5), 1092-1099, 2010
6112010
The extracellular signal–regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis
F Bost, M Aouadi, L Caron, P Even, N Belmonte, M Prot, C Dani, ...
Diabetes 54 (2), 402-411, 2005
4112005
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
YY Wang, C Attané, D Milhas, B Dirat, S Dauvillier, A Guerard, J Gilhodes, ...
JCI insight 2 (4), 2017
3872017
Hypoxia decreases insulin signaling pathways in adipocytes
C Regazzetti, P Peraldi, T Grémeaux, R Najem-Lendom, I Ben-Sahra, ...
Diabetes 58 (1), 95-103, 2009
3322009
The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin
O Potapova, A Haghighi, F Bost, C Liu, MJ Birrer, R Gjerset, D Mercola
Journal of Biological Chemistry 272 (22), 14041-14044, 1997
2851997
Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage
F Bost, L Caron, I Marchetti, C Dani, YLE MARCHAND-BRUSTEL, ...
Biochemical Journal 361 (3), 621-627, 2002
2502002
Inter‐α‐trypsin inhibitor proteoglycan family: A group of proteins binding and stabilizing the extracellular matrix
F Bost, M Diarra‐Mehrpour, JP Martin
European Journal of Biochemistry 252 (3), 339-346, 1998
2421998
Role of MAPKs in development and differentiation: lessons from knockout mice
M Aouadi, B Binetruy, L Caron, Y Le Marchand-Brustel, F Bost
Biochimie 88 (9), 1091-1098, 2006
2222006
Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
Y Li, B Lin, A Agadir, R Liu, MI Dawson, JC Reed, JA Fontana, F Bost, ...
Molecular and cellular biology 18 (8), 4719-4731, 1998
2151998
Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans
C Dray, C Debard, J Jager, E Disse, D Daviaud, P Martin, C Attané, ...
American journal of physiology-endocrinology and metabolism 298 (6), E1161-E1169, 2010
2102010
Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages
M Aouadi, K Laurent, M Prot, Y Le Marchand-Brustel, B Binétruy, F Bost
Diabetes 55 (2), 281-289, 2006
2102006
The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
F Bost, R McKay, N Dean, D Mercola
Journal of Biological Chemistry 272 (52), 33422-33429, 1997
1981997
The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells
F Bost, R McKay, M Bost, O Potapova, NM Dean, D Mercola
Molecular and cellular biology 19 (3), 1938-1949, 1999
1901999
Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death
I Ben-Sahra, B Dirat, K Laurent, A Puissant, P Auberger, A Budanov, ...
Cell Death & Differentiation 20 (4), 611-619, 2013
1632013
The metabolic modulator PGC-1α in cancer
F Bost, L Kaminski
American journal of cancer research 9 (2), 198, 2019
1622019
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20